Inventor

James F. Young

Inventor
Potomac, MD, US

Overview

18→
Patents
2003–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes34%
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C12NMicroorganisms or enzymes6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
A61QSpecific use of cosmetics or similar toiletry preparations2%
PatentTitleYear
11,110,044Skincare treatment20218,742,089'Methods and compositions for expressing negative-sense viral RNA in canine cells'20148,404,236'Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells'20138,278,433'Methods and compositions for expressing negative-sense viral RNA in canine cells'20128,153,133'High potency recombinant antibodies and method for producing them'20128,137,670'Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells'20127,847,082'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'20107,790,434'Methods and compositions for expressing negative-sense viral RNA in canine cells'20107,740,851'Ultra high affinity neutralizing antibodies'20107,700,735'High potency recombinant antibodies and method for producing them'20107,635,568'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'20097,553,489'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'20097,323,172'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'20087,229,619'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'20077,179,900'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'20076,855,493'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'20056,818,216'Anti-RSV antibodies'20046,656,467'Ultra high affinity neutralizing antibodies'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2008Patents assigned to MEDIMMUNE INC (6)· patent assignee history
2003–2010Based in Darnestown, MD, US· patent location history
2005–2014Based in Potomac, MD, US· patent location history
2009–2014Patents assigned to MEDIMMUNE LLC (11)· patent assignee history
2012–2013Patents assigned to WU HERREN (3)· patent assignee history
2012–2013Patents assigned to YOUNG JAMES F (3)· patent assignee history
2012–2013Patents assigned to CHOWDHURY PARTHA S (2)· patent assignee history
2021Based in Hull, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MEDIMMUNE LLC112009–2014
MEDIMMUNE INC62003–2008
WU HERREN32012–2013
YOUNG JAMES Fself32012–2013
CHOWDHURY PARTHA S22012–2013
Locations
LocationPatentsSpan
Potomac, Maryland, US132005–2014
Darnestown, Maryland, US42003–2010
Hull, GB12021